个人信息
Personal Information
联系方式
Contact Information
个人简介
Personal Profile
李昂教授是重症医学专业的学科带头人，从事重症医学的临床和研究三十余年，重点研究领域为脓毒症和多器官衰竭的发病机制和临床救治、公共卫生应急管理。发表学术论文90余篇，SCI论文30余篇，承担及参与国家级及省部级课题12项，获得局级以上科研奖项3项目。
学术机构任职：曾任中国中西医结合学会重症分会副主任委员，北京医学会重症医学分会副主任委员等，北京市重症医学质量控制和改进中心主任，中国医师协会体外生命支持分会副主任委员，中国医师协会中西医结合急救专业分会副主任委员，北京中西医结合学会急救专业委员会主任委员，中国病理生理学会危重病医学专业委员会常委，中国医师协会危重病分会常委，中西医结合学会常务理事，中国老年保健医学研究会 理事，北京市健康管理学会副会长等。
学校任职：曾任北京大学重症医学系副主任，首都医科大学重症医学系副主任，首都医科大学传染病系主任等。
获奖：全国先进工作者，北京市首都劳动奖章，北京市优秀人才青年骨干，曾获中国中西医结合学会科学技术二等奖，北京市科技进步三等奖和华夏医学奖等奖项。
首都医科大学附属北京地坛医院重症医学科是国家临床重点专科建设单位、北京市临床重点专科（重症医学）。
1. 获奖：中国中西医结合学会科技进步二等奖1项、北京科技进步奖二等奖1项
2. 发表论文(近年）
（1）Ang Li（通讯作者），Hua,M., et al., The novel outer membrane protein from OprD/Occ family is associatedwith hypervirulence of carbapenem resistant Acinetobacter baumannii ST2/KL22.Virulence, 2021. 12(1): p. 1-11.
（2）Ang Li（通讯作者），JingyuanLiu, Yulan Sun2,*, Weifeng Shi3,*, The first imported case of Rift Valley feverin China reveals a genetic reassortment of different viral lineages. EmergingMicrobes & Infections(2017)6,e4;published online 18 January 2017
（3）Ang Li（通讯作者），Liu,J, et al.The dual role of anti-viral therapy in the treatment of Coronavirusdisease 2019. European review for medical and pharmacological sciences, 2020.24(22): p. 11939-11944.
（4）Ang Li（通讯作者）.Guo,H., et al., Continuous renal replacement therapy in patients with HIV/AIDS. BMCNephrol, 2020. 21(1): p. 95.
(5)Ang Li（通讯作者）,Zhang,N., et al., Circulating Rather Than Alveolar Extracellular DeoxyribonucleicAcid Levels Predict Outcomes in Influenza. J Infect Dis, 2020. 222(7): p.1145-1154.
(6)Ang Li（通讯作者）,DuCJ, et al., Differences and similarities of high-resolution computed tomographyfeatures between pneumocystis pneumonia and cytomegalovirus pneumonia in AIDSpatients. Infect Dis Poverty, 2020. 9(1): p. 149.
(7)Ang Li（通讯作者）,Zhou,H., et al., Development of early warning and rapid response system for patientswith novel coronavirus pneumonia (COVID-19): A research protocol. Medicine(Baltimore), 2020. 99(34): p. e21874.
(8)Ang Li（通讯作者）, Xiong,J., et al., Acute kidney injury in critically ill cirrhotic patients withspontaneous bacterial peritonitis: a comparison of KDIGO and ICA criteria. ArchMed Sci, 2020. 16(3): p. 569-576.
(9)Ang Li（通讯作者）,DuJ, et al., PDK1/mTOR Signaling in Myeloid Cells Differentially Regulates theEarly and Late Stages of Sepsis.Mediators Inflamm, 2020. 2020: p. 5437175.
(10)Ang Li（通讯作者). Li, C., et al., Extracorporeal membraneoxygenation programs for COVID-19 in China. Crit Care, 2020. 24(1): p. 317.
(11)Ang Li（通讯作者）, Kong, Y., et al., Storm of soluble immune checkpoints associated withdisease severity of COVID-19. Signal Transduct Target Ther, 2020. 5(1): p. 192.
(12）Ang Li（通讯作者），Guo, H., et al., Acute versus acute-on-chronic liver failure: comparative analysis of clinical
outcomes in Beijing, China. BMC Gastroenterol, 2025. 25(1): p. 637.
(13)Ang Li（通讯), Qi, W, et al. Sepsis with Cancer is Marked by a Dysregulated Myeloid Cell Compartment:
A Pilot Study. J Inflamm Res, 2025. 18: p. 8643-8656.
(14)Ang Li(通讯），Hao, J., et al., High-Flow Nasal Cannula Oxygen Therapy versus Non-Invasive Ventilation in AIDS
Patients with Acute Respiratory Failure: A Randomized Controlled Trial. J Clin Med, 2023. 12(4).
（15)Qi, W., J. Liu and A. Li#, Regional Citrate Anticoagulation or Heparin Anticoagulation for Renal Replacement Therapy in Patients With Liver Failure: A Systematic Review and Meta-Analysis. Clin Appl Thromb Hemost, 2023. 29: p. 10760296231174001
文件上传中...
